1
|
Wu M, Pei Z, Long G, Chen H, Jia Z, Xia W. Mitochondrial antiviral signaling protein: a potential therapeutic target in renal disease. Front Immunol 2023; 14:1266461. [PMID: 37901251 PMCID: PMC10602740 DOI: 10.3389/fimmu.2023.1266461] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/25/2023] [Accepted: 09/26/2023] [Indexed: 10/31/2023] Open
Abstract
Mitochondrial antiviral signaling protein (MAVS) is a key innate immune adaptor on the outer mitochondrial membrane that acts as a switch in the immune signal transduction response to viral infections. Some studies have reported that MAVS mediates NF-κB and type I interferon signaling during viral infection and is also required for optimal NLRP3 inflammasome activity. Recent studies have reported that MAVS is involved in various cancers, systemic lupus erythematosus, kidney diseases, and cardiovascular diseases. Herein, we summarize the structure, activation, pathophysiological roles, and MAVS-based therapies for renal diseases. This review provides novel insights into MAVS's role and therapeutic potential in the pathogenesis of renal diseases.
Collapse
Affiliation(s)
- Meng Wu
- Department of Clinical Laboratory, Children’s Hospital of Nanjing Medical University, Nanjing, China
| | - Zhiyin Pei
- Department of Clinical Laboratory, Children’s Hospital of Nanjing Medical University, Nanjing, China
| | - Guangfeng Long
- Department of Clinical Laboratory, Children’s Hospital of Nanjing Medical University, Nanjing, China
| | - Hongbing Chen
- Department of Clinical Laboratory, Children’s Hospital of Nanjing Medical University, Nanjing, China
| | - Zhanjun Jia
- Department of Nephrology, Children’s Hospital of Nanjing Medical University, Nanjing, China
- Jiangsu Key Laboratory of Pediatrics, Nanjing Medical University, Nanjing, China
| | - Weiwei Xia
- Department of Clinical Laboratory, Children’s Hospital of Nanjing Medical University, Nanjing, China
- Department of Nephrology, Children’s Hospital of Nanjing Medical University, Nanjing, China
- Jiangsu Key Laboratory of Pediatrics, Nanjing Medical University, Nanjing, China
| |
Collapse
|
2
|
Abstract
Pyroptosis is a form of regulated cell death that is mediated by the membrane-targeting, pore-forming gasdermin family of proteins. Pyroptosis was initially described as a caspase 1- and inflammasome-dependent cell death pathway typified by the loss of membrane integrity and the secretion of cytokines such as IL-1β. However, gasdermins are now recognized as the principal effectors of this form of regulated cell death; activated gasdermins insert into cell membranes, where they form pores that result in the secretion of cytokines, alarmins and damage-associated molecular patterns and cause cell membrane rupture. It is now evident that gasdermins can be activated by inflammasome- and caspase-independent mechanisms in multiple cell types and that crosstalk occurs between pyroptosis and other cell death pathways. Although they are important for host antimicrobial defence, a growing body of evidence supports the notion that pyroptosis and gasdermins have pathological roles in cancer and several non-microbial diseases involving the gut, liver and skin. The well-documented roles of inflammasome activity and apoptosis pathways in kidney diseases suggests that gasdermins and pyroptosis may also be involved to some extent. However, despite some evidence for involvement of pyroptosis in the context of acute kidney injury and chronic kidney disease, our understanding of gasdermin biology and pyroptosis in the kidney remains limited.
Collapse
|
3
|
Mohammed Mohsen S, Wisam malik A. Prevalence of antibodies in Iraqi Urinary Tract Infection patients using radial immunodiffusion (RID) assay. BIONATURA 2021. [DOI: 10.21931/rb/2021.06.04.23] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022] Open
Abstract
Urinary Tract Infection (UTI) is an infection every place in the urinary tract that may be in the urethra, bladder, or kidneys by microbes. Greatest UTIs are affected by bacteria, but some are affected by fungi and, in rare cases, by viruses. UTI is the most significant common infection in humans. This study deals with the prevalence of antibodies in UTI patients; this study aims to determine the level of antibodies in UTI patients and compare with healthy controls by using the radial immunodiffusion (RID) test. The study was done during the period November 2019 to April 2020 on UTI Iraqi patients. The study included 40 patients and 20 healthy controls. Results show UTI infection occurs in females more than males also; the mean age is 40 years. All the patients with UTI showed decreased IgM serum levels and increased IgG compared with the control group. IgG, IgG, and IgM showed high significance between two UTI patients and the control group groups, while IgM doesn’t show significant differences between study groups.
Collapse
Affiliation(s)
| | - Anas Wisam malik
- Middle Technical University, Baquba Technical Institute, Baquba, Iraq
| |
Collapse
|
4
|
Ambite I, Butler D, Wan MLY, Rosenblad T, Tran TH, Chao SM, Svanborg C. Molecular determinants of disease severity in urinary tract infection. Nat Rev Urol 2021; 18:468-486. [PMID: 34131331 PMCID: PMC8204302 DOI: 10.1038/s41585-021-00477-x] [Citation(s) in RCA: 24] [Impact Index Per Article: 8.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 05/07/2021] [Indexed: 02/06/2023]
Abstract
The most common and lethal bacterial pathogens have co-evolved with the host. Pathogens are the aggressors, and the host immune system is responsible for the defence. However, immune responses can also become destructive, and excessive innate immune activation is a major cause of infection-associated morbidity, exemplified by symptomatic urinary tract infections (UTIs), which are caused, in part, by excessive innate immune activation. Severe kidney infections (acute pyelonephritis) are a major cause of morbidity and mortality, and painful infections of the urinary bladder (acute cystitis) can become debilitating in susceptible patients. Disease severity is controlled at specific innate immune checkpoints, and a detailed understanding of their functions is crucial for strategies to counter microbial aggression with novel treatment and prevention measures. One approach is the use of bacterial molecules that reprogramme the innate immune system, accelerating or inhibiting disease processes. A very different outcome is asymptomatic bacteriuria, defined by low host immune responsiveness to bacteria with attenuated virulence. This observation provides the rationale for immunomodulation as a new therapeutic tool to deliberately modify host susceptibility, control the host response and avoid severe disease. The power of innate immunity as an arbitrator of health and disease is also highly relevant for emerging pathogens, including the current COVID-19 pandemic.
Collapse
Affiliation(s)
- Ines Ambite
- grid.4514.40000 0001 0930 2361Department of Microbiology, Immunology and Glycobiology, Institute of Laboratory Medicine, Lund University, Lund, Sweden
| | - Daniel Butler
- grid.4514.40000 0001 0930 2361Department of Microbiology, Immunology and Glycobiology, Institute of Laboratory Medicine, Lund University, Lund, Sweden
| | - Murphy Lam Yim Wan
- grid.4514.40000 0001 0930 2361Department of Microbiology, Immunology and Glycobiology, Institute of Laboratory Medicine, Lund University, Lund, Sweden
| | - Therese Rosenblad
- grid.4514.40000 0001 0930 2361Department of Microbiology, Immunology and Glycobiology, Institute of Laboratory Medicine, Lund University, Lund, Sweden
| | - Thi Hien Tran
- grid.4514.40000 0001 0930 2361Department of Microbiology, Immunology and Glycobiology, Institute of Laboratory Medicine, Lund University, Lund, Sweden
| | - Sing Ming Chao
- Nephrology Service, Department of Paediatrics, KK Hospital, Singapore, Singapore
| | - Catharina Svanborg
- grid.4514.40000 0001 0930 2361Department of Microbiology, Immunology and Glycobiology, Institute of Laboratory Medicine, Lund University, Lund, Sweden
| |
Collapse
|
5
|
Inflammasome genetics and complex diseases: a comprehensive review. Eur J Hum Genet 2020; 28:1307-1321. [PMID: 32499599 PMCID: PMC7608315 DOI: 10.1038/s41431-020-0631-y] [Citation(s) in RCA: 18] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/16/2019] [Revised: 03/12/2020] [Accepted: 04/14/2020] [Indexed: 02/07/2023] Open
Abstract
The inflammasome is a cytoplasmic multiprotein complex responsible for the activation of inflammatory caspases (caspase-1, -4, and -5) in response to pathogen- and/or damage-associated molecular patterns or to homeostasis-altering molecular pathways, and for the consequent release of the pro-inflammatory cytokines interleukin (IL)-1ß and IL-18. Taking in account the complexity of inflammasome activation and that several regulatory steps are involved in maintaining its physiologic role in homeostasis and innate immune response, it does not surprise that several genetic variants in inflammasome components have been associated with common pathologies in the general population, such as autoimmune disorders, cardiovascular diseases, obesity and associated metabolic syndrome, neurodegenerative diseases, and cancer. Moreover, the susceptibility to infectious agents and/or to develop severe complications during infections also has been related to inflammasome genetics. In this work, we revised genetic association studies about polymorphisms of main inflammasome genes in sterile as well as infectious diseases, trying to depict the genetic contribution of inflammasome in disease pathogenesis.
Collapse
|
6
|
Murphy AM, Smith CE, Murphy LM, Follis JL, Tanaka T, Richardson K, Noordam R, Lemaitre RN, Kähönen M, Dupuis J, Voortman T, Marouli E, Mook‐Kanamori DO, Raitakari OT, Hong J, Dehghan A, Dedoussis G, de Mutsert R, Lehtimäki T, Liu C, Rivadeneira F, Deloukas P, Mikkilä V, Meigs JB, Uitterlinden A, Ikram MA, Franco OH, Hughes M, O' Gaora P, Ordovás JM, Roche HM. Potential Interplay between Dietary Saturated Fats and Genetic Variants of the NLRP3 Inflammasome to Modulate Insulin Resistance and Diabetes Risk: Insights from a Meta-Analysis of 19 005 Individuals. Mol Nutr Food Res 2019; 63:e1900226. [PMID: 31432628 PMCID: PMC6864231 DOI: 10.1002/mnfr.201900226] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/05/2019] [Revised: 07/12/2019] [Indexed: 12/13/2022]
Abstract
SCOPE Insulin resistance (IR) and inflammation are hallmarks of type 2 diabetes (T2D). The nod-like receptor pyrin domain containing-3 (NLRP3) inflammasome is a metabolic sensor activated by saturated fatty acids (SFA) initiating IL-1β inflammation and IR. Interactions between SFA intake and NLRP3-related genetic variants may alter T2D risk factors. METHODS Meta-analyses of six Cohorts for Heart and Aging Research in Genomic Epidemiology Consortium (n = 19 005) tested interactions between SFA and NLRP3-related single-nucleotide polymorphisms (SNPs) and modulation of fasting insulin, fasting glucose, and homeostasis model assessment of insulin resistance. RESULTS SFA interacted with rs12143966, wherein each 1% increase in SFA intake increased insulin by 0.0063 IU mL-1 (SE ± 0.002, p = 0.001) per each major (G) allele copy. rs4925663, interacted with SFA (β ± SE = -0.0058 ± 0.002, p = 0.004) to increase insulin by 0.0058 IU mL-1 , per additional copy of the major (C) allele. Both associations are close to the significance threshold (p < 0.0001). rs4925663 causes a missense mutation affecting NLRP3 expression. CONCLUSION Two NLRP3-related SNPs showed potential interaction with SFA to modulate fasting insulin. Greater dietary SFA intake accentuates T2D risk, which, subject to functional validation, may be further elaborated depending on NLRP3-related genetic variants.
Collapse
Affiliation(s)
- Aoife M. Murphy
- Nutrigenomics Research GroupConway Institute of Biomedical and Biomolecular SciencesUniversity College DublinBelfieldDublin 4, D04 V1W8Ireland
| | - Caren E. Smith
- Jean Mayer USDA Human Nutrition Research Centre on AgingTufts UniversityBostonMA02111USA
| | - Leanne M. Murphy
- UCD School of Biomolecular and Biomedical ScienceConway Institute of Biomedical and Biomolecular SciencesUniversity College DublinBelfieldDublin 4, D04 V1W8Ireland
| | - Jack L. Follis
- Department of MathematicsUniversity of St. ThomasHoustonTX77006‐4626USA
| | - Toshiko Tanaka
- Translational Gerontology BranchNational Institute on AgingBaltimoreMD21224USA
| | - Kris Richardson
- Jean Mayer USDA Human Nutrition Research Centre on AgingTufts UniversityBostonMA02111USA
| | - Raymond Noordam
- Department of Internal MedicineSection of Gerontology and Geriatrics, Leiden University Medical CenterLeiden2333 ZA.The Netherlands
| | | | - Mika Kähönen
- Department of Clinical PhysiologyTampere University Hospital and University of Tampere School of Medicine33521TampereFinland
| | - Josée Dupuis
- Department of BiostatisticsBoston University School of Public HealthBostonMA02130USA
| | - Trudy Voortman
- Department of EpidemiologyErasmus MC‐University Medical CenterPostbus 2040, 3000 CARotterdamThe Netherlands
| | - Eirini Marouli
- William Harvey Research InstituteBarts and The London School of Medicine and DentistryQueen Mary University of LondonLondonE1 4NSUK
| | - Dennis O. Mook‐Kanamori
- Department of Clinical Epidemiology and Department of Public Health and Primary CareLeiden University Medical CenterAlbinusdreef 22333 ZALeidenThe Netherlands
| | - Olli T. Raitakari
- Department of Clinical Physiology and Nuclear MedicineTurku University Hospital, and Research Centre of Applied and Preventive Cardiovascular Medicine, University of Turku20521TurkuFinland
| | - Jaeyoung Hong
- Department of BiostatisticsBoston University School of Public HealthBostonMA02130USA
| | - Abbas Dehghan
- Department of EpidemiologyErasmus MC‐University Medical CenterPostbus 2040, 3000 CARotterdamThe Netherlands
| | - George Dedoussis
- Department of Nutrition and DieteticsSchool of Health Science and Education, Harokopio UniversityEl. Venizelou 7017671AthensGreece
| | - Renée de Mutsert
- Department of Clinical Epidemiology and Department of Public Health and Primary CareLeiden University Medical CenterAlbinusdreef 22333 ZALeidenThe Netherlands
| | - Terho Lehtimäki
- Department of Clinical ChemistryFimlab Laboratories and Finnish Cardiovascular Research Center–TampereFaculty of Medicine and Life Sciences, University of TampereTampere33520Finland
| | - Ching‐Ti Liu
- Department of BiostatisticsBoston University School of Public HealthBostonMA02130USA
| | - Fernando Rivadeneira
- Department of Internal MedicineErasmus University Medical CenterPostbus 2040, 3000 CARotterdamThe Netherlands
| | - Panagiotis Deloukas
- William Harvey Research InstituteBarts and The London School of Medicine and DentistryQueen Mary University of LondonLondonE1 4NSUK
| | - Vera Mikkilä
- Division of NutritionDepartment of Food and Environmental Sciences00014HelsinkiFinland
| | - James B. Meigs
- Division of General Internal MedicineMassachusetts General HospitalBostonMA02114USA
- Harvard Medical SchoolBostonMA02115USA
- Broad InstituteCambridgeMA02142USA
| | - Andre Uitterlinden
- Department of Internal MedicineErasmus University Medical CenterPostbus 2040, 3000 CARotterdamThe Netherlands
| | - Mohammad A. Ikram
- Department of EpidemiologyErasmus MC‐University Medical CenterPostbus 2040, 3000 CARotterdamThe Netherlands
| | - Oscar H. Franco
- Department of EpidemiologyErasmus MC‐University Medical CenterPostbus 2040, 3000 CARotterdamThe Netherlands
| | - Maria Hughes
- Nutrigenomics Research GroupConway Institute of Biomedical and Biomolecular SciencesUniversity College DublinBelfieldDublin 4, D04 V1W8Ireland
| | - Peadar O' Gaora
- UCD School of Biomolecular and Biomedical ScienceConway Institute of Biomedical and Biomolecular SciencesUniversity College DublinBelfieldDublin 4, D04 V1W8Ireland
| | - José M. Ordovás
- Jean Mayer USDA Human Nutrition Research Centre on AgingTufts UniversityBostonMA02111USA
- Centro Nacional de Investigaciones Cardiovasculares (CNIC)28029MadridSpain
- IMDEA Food Institute, CEI UAM + CSICE ‐ 28049MadridSpain
| | - Helen M. Roche
- Nutrigenomics Research GroupConway Institute of Biomedical and Biomolecular SciencesUniversity College DublinBelfieldDublin 4, D04 V1W8Ireland
- Institute For Global Food SecurityQueen's University BelfastNorthern Ireland
| |
Collapse
|
7
|
Genetic Polymorphisms of IL1B, IL6, and TNFα in a Chinese Han Population with Pulmonary Tuberculosis. BIOMED RESEARCH INTERNATIONAL 2018; 2018:3010898. [PMID: 29888256 PMCID: PMC5977055 DOI: 10.1155/2018/3010898] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Subscribe] [Scholar Register] [Received: 12/14/2017] [Revised: 03/21/2018] [Accepted: 04/08/2018] [Indexed: 02/05/2023]
Abstract
Background The factors that predispose to pulmonary tuberculosis (PTB) are not fully understood. Previous studies have shown that cytokine gene polymorphisms were associated with PTB. Objectives In this study, we have investigated the relationship between ILB, IL6, and TNFα polymorphisms and a predisposition to Mycobacterium tuberculosis (MTB) infection and PTB. Methods A total of 209 cases of PTB, 201 subjects with latent TB infection (LTBI), and 204 healthy controls (HCS) were included in this study. Logistic regression analyses under allelic, homozygous, and heterozygous models were used to calculate P values, odds ratios (ORs), and 95% confidence intervals (CIs) for assessing the association between single nucleotide polymorphisms (SNPs) and disease risk, adjusting for sex and age. Genotyping was conducted using the improved multiplex ligase detection reaction (iMLDR) method. Results When comparing PTB patients with LTBI subjects, significant associations with disease development were observed for SNPs of IL6 and TNFα. When comparing LTBI subjects with HCS, IL1B polymorphisms were significantly associated with LIBI. Haplotype analyses suggested that the CGG haplotype of IL1B was associated with an increased risk of PTB (P = 0.039, OR = 1.34, 95% CI: 1.01–1.76), while the TTGCG haplotype of TNFα was a protective factor against PTB (P = 0.039, OR = 0.66, 95% CI: 0.44–0.98). Conclusion Our study demonstrated that IL1B variants were related to LTBI and IL6 and TNFα variants were associated with PTB.
Collapse
|
8
|
Soares JL, Fernandes FP, Patente TA, Monteiro MB, Parisi MC, Giannella-Neto D, Corrêa-Giannella ML, Pontillo A. Gain-of-function variants in NLRP1 protect against the development of diabetic kidney disease: NLRP1 inflammasome role in metabolic stress sensing? Clin Immunol 2018; 187:46-49. [DOI: 10.1016/j.clim.2017.10.003] [Citation(s) in RCA: 21] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/25/2017] [Revised: 09/13/2017] [Accepted: 10/10/2017] [Indexed: 12/20/2022]
|
9
|
da Silva WC, Reis EC, Oshiro TM, Pontillo A. Genetics of Inflammasomes. EXPERIENTIA SUPPLEMENTUM (2012) 2018; 108:321-341. [PMID: 30536178 DOI: 10.1007/978-3-319-89390-7_14] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/09/2023]
Abstract
Mutations in inflammasome genes are responsible for rare monogenic and polygenic autoinflammatory diseases. On the other side, genetic polymorphisms in the same molecules contribute to the development of common multifactorial diseases (i.e., autoimmune diseases, cardiovascular pathologies, cancer). In this chapter we depicted the current knowledge about inflammasome genetics.
Collapse
Affiliation(s)
- Wanessa Cardoso da Silva
- Laboratório de Investigação em Dermatologia e Imunodeficiências, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, São Paulo, SP, Brasil.
- Avenida Dr. Enéas de Carvalho Aguiar, 470 - Instituto de Medicina Tropical (IMT) Prédio 2 - 3° andar, São Paulo, SP, Brasil.
| | - Edione C Reis
- Laboratório de Imunogenética, Departamento de Imunologia, Instituto de Ciências Biomédicas, Universidade de São Paulo, São Paulo, SP, Brasil
- Avenida Prof. Lineu Prestes, 1730 - 05508-000 Cidade Universitária, São Paulo, SP, Brasil
| | - Telma M Oshiro
- Laboratório de Investigação em Dermatologia e Imunodeficiências, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, São Paulo, SP, Brasil
- Avenida Dr. Enéas de Carvalho Aguiar, 470 - Instituto de Medicina Tropical (IMT) Prédio 2 - 3° andar, São Paulo, SP, Brasil
| | - Alessandra Pontillo
- Laboratório de Imunogenética, Departamento de Imunologia, Instituto de Ciências Biomédicas, Universidade de São Paulo, São Paulo, SP, Brasil
- Avenida Prof. Lineu Prestes, 1730 - 05508-000 Cidade Universitária, São Paulo, SP, Brasil
| |
Collapse
|
10
|
Purves JT, Hughes FM. Inflammasomes in the urinary tract: a disease-based review. Am J Physiol Renal Physiol 2016; 311:F653-F662. [PMID: 27170685 DOI: 10.1152/ajprenal.00607.2015] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/04/2016] [Accepted: 05/04/2016] [Indexed: 12/28/2022] Open
Abstract
Inflammasomes are supramolecular structures that sense molecular patterns from pathogenic organisms or damaged cells and trigger an innate immune response, most commonly through production of the proinflammatory cytokines IL-1β and IL-18, but also through less understood mechanisms independent of these cytokines. Great strides have been made in understanding these structures and their dysfunction in various inflammatory diseases, lending new insights into urological and renal problems. From a clinical perspective, benign urinary pathology almost universally involves the inflammatory process, and understanding how inflammasomes translate etiological conditions (diabetes, obstruction, stones, urinary tract infections, etc.) into acute and chronic inflammatory responses is critical to understanding these diseases at a molecular level. To date, inflammasome components have been found in the bladder, prostate, and kidney and have been shown to be activated in response to several infectious and noninfectious insults. In this review, we summarize what is known regarding inflammasomes in both the upper and lower urinary tract and describe several common disease states where they potentially play critical roles.
Collapse
Affiliation(s)
- J Todd Purves
- Division of Urology, Department of Surgery, Duke University Medical Center, Durham, North Carolina
| | - F Monty Hughes
- Division of Urology, Department of Surgery, Duke University Medical Center, Durham, North Carolina
| |
Collapse
|